Klivira
Request demo

Navigating Anthem (Elevance Health) IVIG Infusion Prior Authorization

Successfully managing Anthem (Elevance Health) IVIG Infusion prior authorization requires a precise understanding of payer-specific requirements and submission pathways. Klivira streamlines this complex process for healthcare providers.

Intravenous Immunoglobulin (IVIG) infusions, critical for numerous immunological and neurological conditions, are consistently subject to rigorous prior authorization (PA) across commercial, Medicare Advantage, and Medicaid managed care plans. For facilities serving Anthem-licensed plan members, navigating these PA requirements efficiently is key to revenue cycle integrity and timely patient care.

Anthem (Elevance Health) Prior Authorization Channels for IVIG

IVIG infusion, typically billed under the medical benefit with relevant CPT/HCPCS codes, primarily routes through Anthem's standard medical prior authorization channels. This involves submissions via the Availity Essentials multi-payer provider workspace or through X12 278 transactions via your clearinghouse. Inpatient admission notification and concurrent review intake also route through Availity.

Accessing IVIG Medical Necessity Criteria and Policy

Anthem-licensed plans publish specific medical policies and clinical utilization management guidelines for IVIG infusions. These policies, often accessible through provider portals via Availity, detail medical necessity criteria, including diagnostic requirements, prior treatment failures, and dosing parameters. Providers must reference the state-specific Anthem plan's policy index, which may cite Anthem-developed criteria or established guidelines like MCG.

Key Elements of Anthem IVIG Policy Review

  • Diagnosis-specific criteria: Verification of an FDA-approved or medically accepted indication for IVIG.
  • Prior conservative treatment: Documentation of trials and failures of less intensive therapies.
  • Site-of-service requirements: Adherence to Anthem's site-of-care policies, which may prefer specific outpatient settings.
  • Dosage and duration: Justification for the requested dose, frequency, and duration of therapy.
  • Documentation of clinical response: For ongoing therapy, evidence of patient benefit and continued medical necessity.

Common Denial Patterns and Appeals for IVIG with Anthem

Denials for Anthem IVIG infusions frequently stem from insufficient documentation of medical necessity, failure to meet step therapy requirements, or non-compliance with active site-of-care policies. Klivira's platform helps proactively address these issues. Appeals follow the standard Anthem operating-company appeals process documented in the provider manual, with peer-to-peer review options available.

Electronic Prior Authorization (ePA) and Turnaround Times

While Elevance Health (through its Anthem operating companies) has participated in Da Vinci Project initiatives, medical benefit PA for IVIG primarily relies on X12 278 transactions or Availity portal submissions. Turnaround times are governed by state-specific commercial insurance regulations and CMS-0057-F for Medicare Advantage and Medicaid managed care plans, mandating 72-hour standard and 24-hour expedited decision timeframes on the phased compliance timeline.

Frequently asked questions

How do I submit an IVIG prior authorization request to Anthem (Elevance Health)?

For most Anthem-licensed plans, IVIG prior authorization requests for the medical benefit are submitted either through the Availity Essentials provider portal or via an X12 278 transaction through your clearinghouse. Ensure all required clinical documentation is attached to support medical necessity.

Where can I find Anthem's medical policies for IVIG infusion?

Anthem's medical policies and clinical utilization management guidelines for IVIG are typically found on the state-specific Anthem provider website, often accessible through Availity. Always verify the policy number, state plan context, and effective date to ensure you are using the most current criteria.

What are common reasons Anthem denies IVIG prior authorizations?

Common denial reasons include lack of documented medical necessity, failure to meet specific step therapy criteria, insufficient clinical documentation, or non-compliance with Anthem's site-of-care policies for infusions. Proactive verification against payer policy is crucial.

Does CMS-0057-F apply to Anthem IVIG prior authorizations?

Yes, for Anthem's Medicare Advantage, Medicaid managed care (under Anthem Medicaid plans and the Wellpoint subsidiary brand), and CHIP managed care lines, CMS-0057-F dictates specific prior authorization decision timeframes (72 hours for standard, 24 hours for expedited requests). Commercial plans are subject to state-specific regulations.

Is IVIG infusion PA handled by Carelon Medical Benefits Management for Anthem?

Generally, IVIG infusion, as a specialty injectable on the medical benefit, is subject to Anthem's direct medical-policy review. It is not typically routed through Carelon Medical Benefits Management, which primarily covers advanced imaging, cardiology, MSK, sleep, and radiation oncology. Always verify the specific plan's current routing for specialty injectables.

Related coverage

Other ivig prior authorization by payer

Other ivig prior authorization by specialty

Ready to automate prior auth for this procedure?

See how Klivira automates prior authorizations for your team.

Request a demo